Mintu Turakhia, MD MAS
August 11th, 2014
What’s the Next Phase for Digoxin in Patients with Atrial Fibrillation?
Mintu Turakhia, MD MAS
Mintu P. Turakhia discusses his observational study of digoxin use and mortality risk in patients with atrial fibrillation, using data from the TREAT-AF study.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?